Results per Page:
Autoantibodies in schizophrenia – is the immune system attacking the brain?
From the Ring lab, Translational Science and Therapeutics Division
Fred Hutch Cancer Center announces 2026 Evergreen Fund awardees
Eight Fred Hutch researchers receive nearly $1 million to advance projects with industry partnership potential
Patients’ own autoantibodies may hold key to boosting cancer immunotherapy response
A study published in Nature finds that some cancer patients can make their “own companion drug,” suggesting a potential template for future treatments
Bioengineer Aaron Ring receives Anderson Family Endowed Chair for Immunotherapy
Chair will support innovative immunotherapeutic approaches to cancer drug target discovery
New approach could make bone marrow transplantation safer, stronger
Tests prevented relapse, limited GVHD in laboratory models of leukemia, multiple myeloma